Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial

Phillip D Monk; Richard J Marsden; Victoria J Tear; Jody Brookes; Toby N Batten; Marcin Mankowski; Felicity J Gabbay; Donna E Davies; Stephen T Holgate; Ling-Pei Ho; Tristan Clark; Ratko Djukanovic; Tom M A Wilkinson; Michael G Crooks; Davinder PS Dosanjh; Salman Siddiqui; Najib M Rahman; Jacklyn A Smith; Alexander Horsley; Timothy W Harrison; Dinesh Saralaya; Lorcan McGarvey; Alastair Watson; Edmund Foster; Adam Fleet; Dave Singh; Sophie Hemmings; Sandra Aitken; Sarah Dudley; Rona Beegan; Angela Thompson; Pedro MB Rodrigues

The Lancet Respiratory Medicine (2021) - Comments
doi: 10.1016/s2213-2600(20)30511-7 issn: 2213-2600 pubmed: 33189161 issn: 2213-2619

Phillip D Monk, Richard J Marsden, Victoria J Tear, Jody Brookes, Toby N Batten, Marcin Mankowski, Felicity J Gabbay, Donna E Davies, Stephen T Holgate, Ling-Pei Ho, Tristan Clark, Ratko Djukanovic, Tom M A Wilkinson, Michael G Crooks, Davinder PS Dosanjh, Salman Siddiqui, Najib M Rahman, Jacklyn A Smith, Alexander Horsley, Timothy W Harrison

Go to article

Elsevier BV